Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation

Frontiers in Immunology

Volumn 2, Issue NOV, 2011, Pages

  Ghebrehiwet, Berhane ^a   Jesty, Jolyon ^a   Xu, Sulan ^a   Vinayagasundaram, Rama ^a   Vinayagasundaram, Uma ^a   Ji, Yan ^a   Valentino, Alisa ^a   Hosszu, Kinga K ^a   Mathew, Sally ^a   Joseph, Kusumam ^b   Kaplan, Allen P ^b   Peerschke, Ellinor I B ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bradykinin; Gc1qr; Inflammation; Kininogen; Vascular permeability

Indexed keywords

EID: 84868578007     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00058     Document Type: Article

References (37)

1. Bhoola, K. D., Figueroa, C. D., and Worthy, K. (1992). Bioregulation of kinins: kallikrein, kininogen and kinases. Pharmacol. Rev. 44, 1-80.
2. Bossi, F., Fischetti, F., Regoli, D., Durigutto, P., Frossi, B., Gobeil, F. Jr., Ghebrehiwet, B., Peerschke, E. I. B., Cicardi, M., and Tedesco, F. (2009). Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J. Allergy Clin. Immunol. 124, 1303-1310.
3. Breslauer, K. J., Frank, R., Blocker, H., and Marky, L. A. (1986). Predicting DNA duplex stability from the base sequence. Proc. Natl. Acad. Sci. U.S.A. 83, 3746-3750.
4. Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A., and McRae, K. R. (1997). Binding of high molecular weight kininogen to human umbilical vein endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100, 1481-1487.
5. Dedio, J., Jahnen-Dechent, W., Bachmann, M., and Muller-Esterl, W. (1998). The multiligand-binding protein gC1q-R, putative C1q receptor, is a mitochondrial protein. J. Immunol. 160, 3534-3542.
6. Erdos, E. G., and Sloane, S. M. (1962).An enzyme in human plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11, 585-592.
7. Ghebrehiwet, B., Jesty, J., and Peerschke, E. I. B. (2002). gC1q-R/p33: structure-function predictions from the crystal structure. Immunobiology 205, 421-432.
8. Ghebrehiwet, B., Lim, B.-L., Kumar, R., Feng, X., and Peerschke, E. I. B. (2001). gC1q-R/p33, a member of a new class of multifunctional and multi-compartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 180, 65-77.
9. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I. B., Willis, A. C., and Reid, K. B. M. (1994). Isolation cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular"heads"of C1q. J. Exp. Med. 179, 1809-1821.
10. Ghebrehiwet, B., Lu, P. D., Zhang, W., Lim, B.-L., Eggleton, P., Leigh, L. E. A., Reid, K. B. M., and Peerschke, E. I. B. (1996). Identification of functional domains on gC1q-R,a cell surface protein,which binds to the globular heads of C1q, using monoclonal antibodies and synthetic peptides. Hybridoma 15, 333-344.
11. Ghebrehiwet, B., and Peerschke, E. I. B. (1998). Structure and function of gC1q-R a multi-ligand binding membrane protein. Immunobiology 199, 225-238.
12. Guo, Y.-L., and Colman, R. W. (2005). Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off. J. Thromb. Haemost. 3, 670-676
13. Hasan, A. A. K., Zisman, T., and Schmaier, A. H. (1998). Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 95, 3615-3620.
14. Herwald, H., Dedio, J., Kellner, R., Loos, M., and Muller-Esterl, W. (1996). Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J. Biol. Chem. 271, 13040-13047.
15. Jiang, J. Y., Zhang, K. A., and Xu, R.-M. (1999). Crystal structure of p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. U.S.A. 96, 3572-3577.
16. Joseph, K., Ghebrehiwet, B., and Kaplan, A. P. (2001a). Activation of the kinin-forming cascade on the surface of endothelial cells. Biochem. J. 382, 71-75.
17. Joseph, K., Ghebrehiwet, B., and Kaplan, A. P. (2001b). Activation of the kinin-forming cascade on the surface of endothelial cells. Biol. Chem. 382, 71-75.
18. Joseph, K., Ghebrehiwet, B., Peerschke, E. I. B., Reid, K. B. M., and Kaplan,A. P. (1996). Identification of the zincdependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor which binds to the globular "heads" of C1q (gC1qR). Proc. Natl. Acad. Sci. U.S.A. 93, 8552-8557.
19. Joseph, K., Tholanikunnel, B. G., Ghebrehiwet, B., and Kaplan, A. P. (2004). Interaction of high molecular weight binding proteins on endothelial cella. Thromb. Haemost. 91, 61-70.
20. Joseph, K., Tholanikunnel, B. G., and Kaplan, A. P. (2002). Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc. Natl. Acad. Sci. U.S.A. 99, 896-900.
21. Joseph, K., Tholanikunnel, B. G., and Kaplan, A. P. (2009). Factor XII-independent cleavage of highmolecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J. Allergy Clin. Immunol. 124, 143-149.
22. Kaplan, A. P. (2004). "Mechanisms of bradykinin generation," in Urticaria and Angioedema, eds M. W. Greaves and A. P. Kaplan (New York: Marcel Decker Inc.), 51-72.
23. Kennet, R. H. (1984). "Enzyme-linked antibody assay with cells attached with polyvinyl chloride plates," in Monoclonal Antibodies, eds R. H. Kennet, T. J. McKearn, and K. B. Bechtol (New York: Plenum Press), 376.
24. Khan, M. M., Bradford, H. N., Isordia Salas, I., Liu, Y., Wu, Y., Espinola, R. G., Ghebrehiwet, B., and Colman, R. W. (2006). High-molecularweight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac1, and gC1qR in monocytes. Arterioscler. Thromb. Vasc. Biol. 26, 2260-2266.
25. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-685.
26. Lim, B.-L., Preissner, K., Ghebrehiwet, B., Leigh, L. E. A., and Reid, K. B. M. (1996). The binding protein for globular "heads" of complement C1q, gC1q-R: functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 271, 26739.
27. Mahdi, F., Shariat-Madar, Z., Todd, R. F. III, Figueroa, C. D., and Schmaier, A. H. (2001). Expression and localization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 97, 2342-2350.
28. Margolius, H. S. (1998). Tissue kallikreins. Structure, regulation and participation in mammalian physiology and disease. Clin. Rev. Allergy Immunol. 16, 332-349.
29. Nguyen, T., Ghebrehiwet, B., and Peerschke, E. I. (2000). Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 68, 2061-2068.
30. Peterson, K., Zhang, W., Lu, P. D., Keilbaugh, S. A., Peerschke, E. I. P., and Ghebrehiwet, B. (1997). The C1q binding membrane proteins cC1q-R and gC1q-R, are released from activated cells. Subcellular localization and immunochemical characterization. Clin. Immunol. Immunopathol. 84, 17-26.
31. Pixley, R. J., Espinola, R. G., Ghebrehiwet, B., Joseph, K., Kao, A., Cines, D. B., and Colman, R. W. (2011). Interaction of high molecular weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by plasmon resonance (BiaCore). Thromb. Haemost. 105, 1053-1059.
32. Reddigari, S., and Kaplan, A. P. (1989). Monoclonal antibody to human high molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood 74, 695-702.
33. Reddigari, S. R., Shibayama, Y., Brunnee, T., and Kaplan, A. P. (1993). Human Hageman factor (factor XII) and high molecular kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11892-11987.
34. Regoli, D., and Barabe, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46.
35. Sethi, S., Herrmann, M., Roller, J., von Müller, L., Peerschke, E. I., Ghebrehiwet, B., Bajric, I., Menger, M. D., and Laschke, M. W. (2011). Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium. Microvasc. Res. 82, 66-72.
36. Shariat-Madar, Z., Mahdi, F., and Schmaier, A. H. (2002). Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277, 17962-17969.
37. van Leuwen, H. C., and O'Hare, P. (2001). Retargeting of the mitochodnrial protein p32/gC1qR to a cytoplasmic compartment and the cell surface. J. Cell Sci. 114, 2115-2123.